Outcome of endoscopic third ventriculostomy: analysis of first 23 cases

Authors

  • Madhukar T. Nayak Department of Neurosurgery,Father Muller Medical College, Mangalore, Karnataka, India
  • Vidyashri Kamath Department of Obstetrics and Gynaecology, Father Muller Medical College, Mangalore, Karnataka, India

Keywords:

Endoscopic Third Ventriculostomy, Hydrocephalus, V P Shunt, Neuroendoscopy, CSF Diversion Procedure, ETV

Abstract

Background: Surgical treatment of hydrocephalus has been in the form of CSF diversion procedures since centuries. The introduction of Neuroendoscope added to the improved optics in the form of advanced lens – rod system and better illumination using xenon cold light source has provided greater impetus to Endoscopic third ventriculostomy (ETV) as a viable and effective treatment modality.

Methods: This retrospective study analyses the clinical and radiological outcome of ETV in the first 23 patients of varied age groups and etiologies operated over a period of 24 months. The follow up duration ranged from 5 months to 30 months. A successful outcome was considered if there was resolution of clinical symptoms and improvement in radiological features of hydrocephalus and no requirement of alternative CSF diversion procedure (V P Shunt). A failure was indicated by either lack of clinical improvement or radiological features of partial or complete resolution of hydrocephalus and need for an alternative CSF diversion procedure (V P Shunt).

Results: The predominant age group was 6-60 years. The age ranged from 1 month to 67 years. The Male: Female ratio was 14:9. The common etiologies were congenital, post infective and intracranial bleed in 26.1% (n=6) each. Favorable outcome was seen in 82.6% of cases. The failure rate was 17.4%. Most no of cases with favorable outcome was seen in 6-60 years age group, whereas >60 years age group had the most no of cases with poor outcome. The overall mortality rate was 21.6 % (n=5). Wound related complication was seen in 1 patient (4.3%).  Two (8.7%) patients required VP shunt post ETV. The cause of mortality was aspiration pneumonitis in 3 cases, CSF metastasis and wound infection in 1 cases each.

Conclusions: ETV is a safe viable and effective alternative for VP shunt as a CSF diversion procedure in the treatment of Hydrocephalus. It provides long lasting and virtually permanent solution due to its non-dependence on hardware and implants. Cost of equipment and availability of surgical expertise are the only impediments to this promising treatment modality.

References

Pereira J, Lamas R, Ayres-Basto M, Seixas ML, Vaz R. Neuroendoscopy in the treatment of obstructive hydrocephaly. Acta Médica Portuguesa. 2002;15(5):355-64.

Li KW, Nelson C, Suk I, Jallo GI. Neuroendoscopy: past, present, and future. Neurosurg Focus. 2005;19(6):E1.

Walker ML. History of ventriculostomy. Neurosurg Clin N Am. 2001;12(1):101-10.

Guzelbag E, Ersahin Y, Mutluer S. Cerebrospinal fluid shunt complications. Turk J Pediatr. 1997;39(3):363-71.

Piatt JH, Jr. Cerebrospinal fluid shunt failure: late is different from early. Pediatr Neurosurg. 1995;23(3):133-9.

Kadrian D, van Gelder J, Florida D, Jones R, Vonau M, Teo C, et al. Long-term reliability of endoscopic third ventriculostomy. Neurosurgery. 2005;56(6):1271-8.

Hopf NJ, Grunert P, Fries G, Resch KD, Perneczky A. Endoscopic third ventriculostomy: outcome analysis of 100 consecutive procedures. Neurosurgery. 1999;44(4):795-804.

Siomin V, Cinalli G, Grotenhuis A, Golash A, Oi S, Kothbauer K, et al. Endoscopic third ventriculostomy in patients with cerebrospinal fluid infection and/or hemorrhage. J Neurosurg. 2002;97(3):519-24.

Beems T, Grotenhuis JA. Is the success rate of endoscopic third ventriculostomy age-dependent? An analysis of the results of endoscopic third ventriculostomy in young children. Childs Nerv Syst. 2002;18(11):605-8.

Vinchon M, Rekate H, Kulkarni AV. Pediatric hydrocephalus outcomes: a review. Fluids Barriers CNS. 2012;9(1):18.

Drake JM, Kulkarni AV, Kestle J. Endoscopic third ventriculostomy versus ventriculoperitoneal shunt in pediatric patients: a decision analysis. Childs Nerv Syst. 2009;25(4):467-72.

Sandberg DI. Endoscopic management of hydrocephalus in pediatric patients: a review of indications, techniques, and outcomes. J Child Neurol. 2008;23(5):550-60.

Tambo FF, Djientcheu V, Chiabi A, Mbarnjuk SA, Walburga YJ, Mbonda E, et al. Our experience in the management of infantile hydrocephalus: a study on thirty-five regrouped cases in Yaounde, Cameroon. Afr J Paediatr Surg. 2011;8(2):199-202.

Warf BC. Hydrocephalus in Uganda: the predominance of infectious origin and primary management with endoscopic third ventriculostomy. J Neurosurg. 2005;102(1 Suppl):1-15.

Drake JM. Endoscopic third ventriculostomy in pediatric patients: the Canadian experience. Neurosurgery. 2007;60(5):881-6.

Drake JM. The surgical management of pediatric hydrocephalus. Neurosurgery. 2008;62 Suppl 2:633-42.

Mohanty A, Vasudev MK, Sampath S, Radhesh S, Sastry Kolluri VR. Failed endoscopic third ventriculostomy in children: management options. Pediatr Neurosurg. 2002;37(6):304-9.

Downloads

Published

2017-02-09

Issue

Section

Original Research Articles